A phase I dose-escalation study of a biosimilar trastuzumab in Chinese metastasis breast cancer patients
2015 · SpringerPlus · 24 citations
https://doi.org/10.1186/s40064-015-1603-5
X
Xinghe Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
128
Papers
1.7K
Citations
20
h-index
39
i10-index
Xinghe Wang is an academic researcher from Xuzhou Medical College. The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & Chronic Lymphocytic Leukemia Research & Peptidase Inhibition and Analysis. The author has an h-index of 20, co-authored 109 publications.
ORCID: 0000-0002-4197-8545Papers by this author
worksEffects of food on pharmacokinetics and safety of metformin hydrochloride tablets: A meta-analysis of pharmacokinetic, bioavailability, or bioequivalence studies
2023 · Heliyon · 14 citations
https://doi.org/10.1016/j.heliyon.2023.e17906
Association between early ondansetron administration and in-hospital mortality in critically ill patients: analysis of the MIMIC-IV database
2022 · Journal of Translational Medicine · 11 citations
https://doi.org/10.1186/s12967-022-03401-y
A multicenter randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Caelyx ® in advanced breast cancer
2022 · Frontiers in Oncology · 8 citations
https://doi.org/10.3389/fonc.2022.1070001
Effect of esketamine on hypotension in women with preoperative anxiety undergoing elective cesarean section: a randomized, double-blind, controlled trial
2024 · Scientific Reports · 8 citations
https://doi.org/10.1038/s41598-024-68155-7
Role of the Ebola membrane in the protection conferred by the three-mAb cocktail MIL77
2018 · Scientific Reports · 7 citations
https://doi.org/10.1038/s41598-018-35964-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat